Cited by 4Gestational Diabetes Research and ManagementMaternal and Perinatal Health InterventionsDiabetes Management and Research

Adherence rates to a prediction tool identifying women with an increased gestational diabetes risk: An implementation study

Open access
van Montfort, Pim, Scheepers, Hubertina C. J., van Dooren, Ivo M. A., Meertens, Linda J. E., Wynants, Laure, Zelis, Maartje, Zwaan, Iris M., Spaanderman, Marc E. A. +1 more·2021·International Journal of Gynecology & Obstetrics

Abstract

Objective: The best screening strategy for gestational diabetes mellitus (GDM) remains a topic of debate. Several organizations made a statement in favor of universal screening, but the volume of oral glucose tolerance tests (OGTT) required may burden healthcare systems. As a result, many countries still rely on selective screening using a checklist of risk factors, but reported diagnostic characteristics vary. Moreover, women's discomfort due to an OGTT is often neglected. Since 2017, obstetric healthcare professionals in a Dutch region assessed women's GDM risk with a prediction model and counseled those with an increased risk regarding an OGTT. Methods: From 2017 to 2018, 865 women were recruited in a multicenter prospective cohort. Results: In total, 385 women (48%) had an increased predicted GDM risk. Of all women, 78% reported that their healthcare professional discussed their GDM risk. Predicted GDM risks were positively correlated with conducting an OGTT. Conclusion: Implementation of a GDM prediction model resulted in moderate rates of OGTTs performed in general, but high rates in high‐risk women. As 25% of women experienced discomfort from the OGTT, a selective screening strategy based on a prediction model with a high detection rate may be an interesting alternative to universal screening. Study cohort registration: Netherlands Trial Register: NTR4143; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4143.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijgo.13517

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Netherlands, other researchers using IADPSG/WHO 2013 criteria diagnosed GDM in 8.2% of patients and in 13.2% of high-risk patients.

    “Other researchers from the Netherlands using the IADPSG/WHO 2013 criteria diagnosed GDM in 8.2% of patients and in 13.2% of GDM high-risk patients [148].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van Montfort, P., Scheepers, H. C. J., van Dooren, I. M. A., Meertens, L. J. E., Wynants, L., Zelis, M., Zwaan, I. M., Spaanderman, M. E. A., & Smits, L. J. M.
Affiliations
  • Department of Epidemiology Care and Public Health Research Institute Maastricht University Maastricht The Netherlands
  • Maastricht University Medical Centre (NL)
  • Department of Obstetrics and Gynecology Sint Jans Gasthuis Weert Weert The Netherlands
  • Maastricht University (NL)
  • Zuyderland Medisch Centrum (NL)
  • Laurentius Ziekenhuis (NL)
  • St.Jans Gasthuis Weert (NL)
Venue
International Journal of Gynecology & Obstetrics
Publisher
Wiley
Published
2021-01-05
Volume
154
Issue
1
Pages
85-91
ISSN
  • 0020-6695 (ISSN-L)
  • 0020-7292
  • 1879-3479
OpenAlex
W3108871458
Cited by
4
References
30
Citations by year
2025: 1 · 2024: 1 · 2022: 2
FWCI
0.31
Type
journal article
Language
en
Open access
Locations
  • International Journal of Gynecology & Obstetrics (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • Lirias (acceptedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion, cc-by-nc-nd)
Funders
ZonMw
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, targeted screening, oral glucose tolerance test, risk counseling, implementation, patient discomfort, universal screening, obstetric care
MeSH terms
Adult, Female, Glucose Tolerance Test, Humans, Mass Screening, Netherlands, Pregnancy, Prospective Studies, Risk Factors, Cohort Studies, Diabetes, Gestational, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review